Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Hansenologia Internationalis (Online) |
Texto Completo: | https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370 |
Resumo: | Leprosy would be an ordinary disease; however, it is not due to its reactive episodes with risk of disability maintaining the stigma related to the leprosy. These reactions and the potential loss of the neural function may happen before, during and after treatment, through a multidrug therapy (MDT). Release from treatment results from the number of doses and regularity of the treatment, when the patient leaves the coefficientsof prevalence. The aim was to evaluate the magnitude of late leprosy reactions and the operational subjects referring to the attendance quality. Charts of the 149 patients that received discharge for leprosy from 1994 to 1999, in CSE Jaraguá - UFU, Brazil, were revised using the Record of Inquiry of Alterations After Cure of the Brazilian Ministry of Health. Of these patients, 34 (23%) presented late reaction, of which 11,76% were paucibacillary (PB) and 88,23% were multibacillary (MB). An average of 3 reactive episodes for borderline patient and 4 episodes for lepromatous patient occurred. Of PB patients, 100% presented reversal reaction (RR). Among MB, 50% presented RR, 40% erythema nodosum leprosum (ENL), 7% isolated neuritis and 3% mixed reaction. In 91% of the cases, the first reactive episode happened in the first year after treatment.There was a positive correlation among medium bacillary index (BI) at diagnosis and the number of reaction episodes during treatment and after release. Among patients with late reaction, 97% used prednisone and 32% thalidomide,meaning 22% and 8% from the total, respectively. Grade of disability 2 and 3 happened in MB patients of the economically active age. It is discussed the need of implementing leprosy control programs for that new group of patients with warranty of treatment, personnel training for simplified monitoring of neuritis and handling of the adverse effects of corticosteroids therapeutics, seeking the prevention of disabilities. |
id |
ILSL-1_428dd6faa58d8bd7d183a501ec1a3002 |
---|---|
oai_identifier_str |
oai:ojs.periodicos.saude.sp.gov.br:article/35370 |
network_acronym_str |
ILSL-1 |
network_name_str |
Hansenologia Internationalis (Online) |
repository_id_str |
|
spelling |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care programOcorrência de reações em pacientes pós-alta por cura de hanseníase: subsídios para implementação de um programa de atenção específicaHanseníaseReações hansênicasProgramas de controlePrevenção de incapacidadesLeprosyLeprosy ReactionLeprosy control programsPrevention of DisabilitiesLeprosy would be an ordinary disease; however, it is not due to its reactive episodes with risk of disability maintaining the stigma related to the leprosy. These reactions and the potential loss of the neural function may happen before, during and after treatment, through a multidrug therapy (MDT). Release from treatment results from the number of doses and regularity of the treatment, when the patient leaves the coefficientsof prevalence. The aim was to evaluate the magnitude of late leprosy reactions and the operational subjects referring to the attendance quality. Charts of the 149 patients that received discharge for leprosy from 1994 to 1999, in CSE Jaraguá - UFU, Brazil, were revised using the Record of Inquiry of Alterations After Cure of the Brazilian Ministry of Health. Of these patients, 34 (23%) presented late reaction, of which 11,76% were paucibacillary (PB) and 88,23% were multibacillary (MB). An average of 3 reactive episodes for borderline patient and 4 episodes for lepromatous patient occurred. Of PB patients, 100% presented reversal reaction (RR). Among MB, 50% presented RR, 40% erythema nodosum leprosum (ENL), 7% isolated neuritis and 3% mixed reaction. In 91% of the cases, the first reactive episode happened in the first year after treatment.There was a positive correlation among medium bacillary index (BI) at diagnosis and the number of reaction episodes during treatment and after release. Among patients with late reaction, 97% used prednisone and 32% thalidomide,meaning 22% and 8% from the total, respectively. Grade of disability 2 and 3 happened in MB patients of the economically active age. It is discussed the need of implementing leprosy control programs for that new group of patients with warranty of treatment, personnel training for simplified monitoring of neuritis and handling of the adverse effects of corticosteroids therapeutics, seeking the prevention of disabilities.A hanseníase seria uma doença comum se não fosse por seus episódios reacionais com risco de incapacidades mantendo o estigma relacionado à "lepra". Essas reações e a perda potencial da função neural podem ocorrer antes, durante e após o tratamento, feito com poliquimioterapia (PQT). A alta por cura se dá pelo número de doses e regularidade do tratamento, quando o paciente sai do registro ativo e dos coeficientes de prevalência. Objetivando avaliar a magnitude das reações hansênicas pós-alta e as questões operacionais referentes a qualidade da assistência, foram revisados prontuários de 149 pacientes quereceberam alta de hanseníase de 1994 a 1999, no Centro de Saúde Escola Jaraguá — UFU, utilizando a Ficha de Investigação de Intercorrências Pós-Alta por Cura do Ministério da Saúde. Destes, 34 (23%) apresentaram reação pós-alta, sendo 11,76% PB e 88,23% MB. Ocorreu uma média de 3 episódios por paciente dimorfo e 4 por paciente virchowiano. Dos PB, 100% apresentaram reação reversa (RR). Entre os MB, 50% apresentaram RR, 40% eritema nodoso hansênico (ENH), 7% neurite isolada e 3% reação mista. Em 91% dos casos, o primeiro episódio reacional ocorreu no primeiro ano pós-tratamento. Houve correlação positiva entre IB médio no diagnóstico e número deepisódios reacionais durante o tratamento e pós-alta. Dos pacientes com reação pós-alta, 97% utilizaram prednisona e 32% talidomida, significando 22% e 8%, respectivamente,dos pacientes em alta. Graus de incapacidade II e Ill ocorreram em MB da faixa etária economicamente ativa.Discute-se a necessidade de implementar programas de controle específicos para esse novo grupo de pacientes, com garantia de medicamentos, capacitação de pessoal para o monitoramento simplificado das neurites e o manejo dos efeitos adversos da terapêutica com corticoesteróides, visando à prevenção de incapacidades.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo2000-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3537010.47878/hi.2000.v25.35370Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 25 No. 1 (2000); 7-16Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 25 n. 1 (2000); 7-161982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLporenghttps://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33802https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33803https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodrigues, Ana Laura PereiraAlmeida, Andrey Peterson deRodrigues, Bethânia de FreitasPinheiro, Carla AparecidaBorges, Daniela SantosMendonça, Marcelo Luiz Holanda deSilva, Vinícius Eustáquio Ferreira daGoulart, Isabela Maria Remarries2023-09-27T14:00:41Zoai:ojs.periodicos.saude.sp.gov.br:article/35370Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2023-09-27T14:00:41Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false |
dc.title.none.fl_str_mv |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program Ocorrência de reações em pacientes pós-alta por cura de hanseníase: subsídios para implementação de um programa de atenção específica |
title |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program |
spellingShingle |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program Rodrigues, Ana Laura Pereira Hanseníase Reações hansênicas Programas de controle Prevenção de incapacidades Leprosy Leprosy Reaction Leprosy control programs Prevention of Disabilities |
title_short |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program |
title_full |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program |
title_fullStr |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program |
title_full_unstemmed |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program |
title_sort |
Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program |
author |
Rodrigues, Ana Laura Pereira |
author_facet |
Rodrigues, Ana Laura Pereira Almeida, Andrey Peterson de Rodrigues, Bethânia de Freitas Pinheiro, Carla Aparecida Borges, Daniela Santos Mendonça, Marcelo Luiz Holanda de Silva, Vinícius Eustáquio Ferreira da Goulart, Isabela Maria Remarries |
author_role |
author |
author2 |
Almeida, Andrey Peterson de Rodrigues, Bethânia de Freitas Pinheiro, Carla Aparecida Borges, Daniela Santos Mendonça, Marcelo Luiz Holanda de Silva, Vinícius Eustáquio Ferreira da Goulart, Isabela Maria Remarries |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Rodrigues, Ana Laura Pereira Almeida, Andrey Peterson de Rodrigues, Bethânia de Freitas Pinheiro, Carla Aparecida Borges, Daniela Santos Mendonça, Marcelo Luiz Holanda de Silva, Vinícius Eustáquio Ferreira da Goulart, Isabela Maria Remarries |
dc.subject.por.fl_str_mv |
Hanseníase Reações hansênicas Programas de controle Prevenção de incapacidades Leprosy Leprosy Reaction Leprosy control programs Prevention of Disabilities |
topic |
Hanseníase Reações hansênicas Programas de controle Prevenção de incapacidades Leprosy Leprosy Reaction Leprosy control programs Prevention of Disabilities |
description |
Leprosy would be an ordinary disease; however, it is not due to its reactive episodes with risk of disability maintaining the stigma related to the leprosy. These reactions and the potential loss of the neural function may happen before, during and after treatment, through a multidrug therapy (MDT). Release from treatment results from the number of doses and regularity of the treatment, when the patient leaves the coefficientsof prevalence. The aim was to evaluate the magnitude of late leprosy reactions and the operational subjects referring to the attendance quality. Charts of the 149 patients that received discharge for leprosy from 1994 to 1999, in CSE Jaraguá - UFU, Brazil, were revised using the Record of Inquiry of Alterations After Cure of the Brazilian Ministry of Health. Of these patients, 34 (23%) presented late reaction, of which 11,76% were paucibacillary (PB) and 88,23% were multibacillary (MB). An average of 3 reactive episodes for borderline patient and 4 episodes for lepromatous patient occurred. Of PB patients, 100% presented reversal reaction (RR). Among MB, 50% presented RR, 40% erythema nodosum leprosum (ENL), 7% isolated neuritis and 3% mixed reaction. In 91% of the cases, the first reactive episode happened in the first year after treatment.There was a positive correlation among medium bacillary index (BI) at diagnosis and the number of reaction episodes during treatment and after release. Among patients with late reaction, 97% used prednisone and 32% thalidomide,meaning 22% and 8% from the total, respectively. Grade of disability 2 and 3 happened in MB patients of the economically active age. It is discussed the need of implementing leprosy control programs for that new group of patients with warranty of treatment, personnel training for simplified monitoring of neuritis and handling of the adverse effects of corticosteroids therapeutics, seeking the prevention of disabilities. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-06-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370 10.47878/hi.2000.v25.35370 |
url |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370 |
identifier_str_mv |
10.47878/hi.2000.v25.35370 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33802 https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33803 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
dc.source.none.fl_str_mv |
Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 25 No. 1 (2000); 7-16 Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 25 n. 1 (2000); 7-16 1982-5161 reponame:Hansenologia Internationalis (Online) instname:Instituto Lauro de Souza Lima (ILSL) instacron:ILSL |
instname_str |
Instituto Lauro de Souza Lima (ILSL) |
instacron_str |
ILSL |
institution |
ILSL |
reponame_str |
Hansenologia Internationalis (Online) |
collection |
Hansenologia Internationalis (Online) |
repository.name.fl_str_mv |
Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL) |
repository.mail.fl_str_mv |
hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br |
_version_ |
1796797579302797312 |